130 related articles for article (PubMed ID: 16835384)
41. Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
Giovannetti E; Laan AC; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):720-5. PubMed ID: 18600531
[TBL] [Abstract][Full Text] [Related]
42. High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidine.
Miwa M; Eda H; Ura M; Ouchi KF; Keith DD; Foley LH; Ishitsuka H
Clin Cancer Res; 1998 Feb; 4(2):493-7. PubMed ID: 9516941
[TBL] [Abstract][Full Text] [Related]
43. Clinical pharmacology and pharmacogenetics of gemcitabine.
Wong A; Soo RA; Yong WP; Innocenti F
Drug Metab Rev; 2009; 41(2):77-88. PubMed ID: 19514966
[TBL] [Abstract][Full Text] [Related]
44. [The assay of intracelluar cytidine deaminase activity and its clinical significance in patient with acute leukemia].
Zhao XS; Sun Zq; Jiang B; Wang de B
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):181-4. PubMed ID: 18458696
[TBL] [Abstract][Full Text] [Related]
45. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.
Weizman N; Krelin Y; Shabtay-Orbach A; Amit M; Binenbaum Y; Wong RJ; Gil Z
Oncogene; 2014 Jul; 33(29):3812-9. PubMed ID: 23995783
[TBL] [Abstract][Full Text] [Related]
46. Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704.
Farrell JJ; Bae K; Wong J; Guha C; Dicker AP; Elsaleh H
Pharmacogenomics J; 2012 Oct; 12(5):395-403. PubMed ID: 21625252
[TBL] [Abstract][Full Text] [Related]
47. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
Eliopoulos N; Bovenzi V; Le NL; Momparler LF; Greenbaum M; Létourneau S; Cournoyer D; Momparler RL
Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308
[TBL] [Abstract][Full Text] [Related]
48. Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
Gilbert JA; Salavaggione OE; Ji Y; Pelleymounter LL; Eckloff BW; Wieben ED; Ames MM; Weinshilboum RM
Clin Cancer Res; 2006 Mar; 12(6):1794-803. PubMed ID: 16551864
[TBL] [Abstract][Full Text] [Related]
49. Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis.
Bøyum A; Tennfjord VA; Gran C; Løvhaug D; Oktedalen O; Brandtzaeg P
J Infect Dis; 2000 Dec; 182(6):1784-7. PubMed ID: 11069255
[TBL] [Abstract][Full Text] [Related]
50. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
Lee JT; Campbell DO; Satyamurthy N; Czernin J; Radu CG
J Nucl Med; 2012 Feb; 53(2):275-80. PubMed ID: 22302964
[TBL] [Abstract][Full Text] [Related]
51. Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells.
Giovannetti E; Leon LG; Bertini S; Macchia M; Minutolo F; Funel N; Alecci C; Giancola F; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):419-26. PubMed ID: 20544530
[TBL] [Abstract][Full Text] [Related]
52. Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma.
Ogawa M; Hori H; Ohta T; Onozato K; Miyahara M; Komada Y
Clin Cancer Res; 2005 May; 11(9):3485-93. PubMed ID: 15867251
[TBL] [Abstract][Full Text] [Related]
53. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
[TBL] [Abstract][Full Text] [Related]
54. Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.
Giordano FA; Sorg UR; Appelt JU; Lachmann N; Bleier S; Roeder I; Kleff V; Flasshove M; Zeller WJ; Allgayer H; von Kalle C; Fruehauf S; Moritz T; Laufs S
Hum Gene Ther; 2011 Jun; 22(6):697-710. PubMed ID: 21319998
[TBL] [Abstract][Full Text] [Related]
55. Chromosomal location, cloning and nucleotide sequence of the Bacillus subtilis cdd gene encoding cytidine/deoxycytidine deaminase.
Song BH; Neuhard J
Mol Gen Genet; 1989 Apr; 216(2-3):462-8. PubMed ID: 2526291
[TBL] [Abstract][Full Text] [Related]
56. Fusion of the lac genes to the promotor for the cytidine deaminase gene of Escherichia coli K-12.
Josephsen J; Hammer-Jespersen K
Mol Gen Genet; 1981; 182(1):154-8. PubMed ID: 6455590
[TBL] [Abstract][Full Text] [Related]
57. Severe or lethal toxicities with nucleosidic analogs: time for action.
Evrard A; Lacarelle B; Ciccolini J
Pharmacogenomics; 2013 Feb; 14(3):227-30. PubMed ID: 23394383
[No Abstract] [Full Text] [Related]
58. Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine: the question is still ongoing.
Giovannetti E; Tibaldi C; Falcone A; Danesi R; Peters GJ
J Clin Oncol; 2010 May; 28(14):e221-2; author reply e223-5. PubMed ID: 20351322
[No Abstract] [Full Text] [Related]
59. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.
Hawley RG; Hawley TS; Fong AZ; Quinto C; Collins M; Leonard JP; Goldman SJ
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10297-302. PubMed ID: 8816794
[TBL] [Abstract][Full Text] [Related]
60. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine.
Choy ATF; Carnevale I; Coppola S; Meijer LL; Kazemier G; Zaura E; Deng D; Giovannetti E
Expert Rev Mol Diagn; 2018 Dec; 18(12):1005-1009. PubMed ID: 30392417
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
